Product NDC: | 65841-027 |
Proprietary Name: | METFORMIN HYDROCHLORIDE |
Non Proprietary Name: | METFORMIN HYDROCHLORIDE |
Active Ingredient(s): | 500 mg/1 & nbsp; METFORMIN HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65841-027 |
Labeler Name: | Cadila Healthcare Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077060 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050928 |
Package NDC: | 65841-027-01 |
Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-027-01) |
NDC Code | 65841-027-01 |
Proprietary Name | METFORMIN HYDROCHLORIDE |
Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-027-01) |
Product NDC | 65841-027 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | METFORMIN HYDROCHLORIDE |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20050928 |
Marketing Category Name | ANDA |
Labeler Name | Cadila Healthcare Limited |
Substance Name | METFORMIN HYDROCHLORIDE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Biguanide [EPC],Biguanides [Chemical/Ingredient] |